Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Higenbottam

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1993
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth HospitalC Dennis, N Caine, L Sharples, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1993
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung TransplantationJ D Cooper, M Billingham, T Egan, et al.
The European Respiratory Journal|August 1, 1995
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceN M Siafakas, P Vermeire, N B Pride, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1991
Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experienceM R de Leval, R Smyth, B Whitehead, et al.
Allergy|May 21, 2018
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapyM Worm, T Higenbottam, O Pfaar, et al.
Intensive Care Medicine|February 21, 1998
UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDSB H Cuthbertson, P Dellinger, O J Dyar, et al.
The Journal of International Medical Research|July 1, 1990
Controlled-release theophylline in the treatment of nocturnal asthmaA J Fairfax, R Clarke, S S Chatterjee, et al.
The World Allergy Organization Journal|November 12, 2019
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testingS Zielen, P Kuna, W Aberer, et al.
Journal of Medical Genetics|October 4, 2000
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJ R Thomson, R D Machado, M W Pauciulo, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 1, 1993
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth HospitalC Dennis, N Caine, L Sharples, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1993
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung TransplantationJ D Cooper, M Billingham, T Egan, et al.
The European Respiratory Journal|August 1, 1995
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceN M Siafakas, P Vermeire, N B Pride, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1991
Heart and lung transplantation for terminal cystic fibrosis. A 4 1/2-year experienceM R de Leval, R Smyth, B Whitehead, et al.
Allergy|May 21, 2018
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapyM Worm, T Higenbottam, O Pfaar, et al.
Intensive Care Medicine|February 21, 1998
UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDSB H Cuthbertson, P Dellinger, O J Dyar, et al.
The Journal of International Medical Research|July 1, 1990
Controlled-release theophylline in the treatment of nocturnal asthmaA J Fairfax, R Clarke, S S Chatterjee, et al.
The World Allergy Organization Journal|November 12, 2019
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testingS Zielen, P Kuna, W Aberer, et al.
Journal of Medical Genetics|October 4, 2000
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJ R Thomson, R D Machado, M W Pauciulo, et al.
Pageof 16